The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksB&M Regulatory News (BME)

Share Price Information for B&M (BME)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 548.20
Bid: 546.40
Ask: 546.60
Change: 13.20 (2.47%)
Spread: 0.20 (0.037%)
Open: 536.60
High: 548.20
Low: 536.20
Prev. Close: 535.00
BME Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Board Appointment

20 Jun 2023 10:01

RNS Number : 2970D
B&M European Value Retail S.A.
20 June 2023
 

 

20 June 2023

B&M European Value Retail S.A.

Board Appointment

 

B&M European Value Retail S.A. (the "Company") announces the following Board changes.

 

Hounaïda Lasry is to be appointed, subject to shareholder approval, as a Non-Executive Director of the Company with effect from 22 September 2023 when she will also join the Remuneration and Nomination Committees.

 

Hounaïda is currently a Non-Executive Director at Britvic plc.

 

Hounaïda had almost 30 years' experience at Procter & Gamble across various sectors (Skin & Personal Care, Pet Food, Sanitary Pads, Diapers and Detergents) and geographies (Europe, Middle East, Africa and Asia). In her final role, she had responsibility for a portfolio of 5 brands across Europe, backed by strong operational experience in leading business turnarounds and organization transformation.

 

From 2016 to 2021, Hounaïda was a Non-Executive Director on the Advisory Board of the Geneva School of Economics and Management.

 

 

Peter Bamford, Chairman, said

 "I am delighted that Hounaïda has agreed to join the Board of B&M. She brings strong commercial international, and strategic instincts and the benefits of experience gained in a wide variety of challenging operational roles within the highly structured and developed consumer facing disciplines of Procter and Gamble. Hounaïda will enhance the diversity of experience and skills on our Board considerably"

 

 

With regard to Hounaïda Lasry's appointment to the Board on 22 September 2023, as there is currently no vacancy in the office of a Director of the Company, in accordance with Luxembourg law, her appointment is required to be approved by a resolution of shareholders at a general meeting of the Company. Accordingly, an Ordinary General Meeting of shareholders is to be convened during September 2023 (the "Meeting") for that purpose. Subject to her appointment being approved at the Meeting, it will take effect on 22 September 2023. Further announcements will be made to confirm when the notice of the Meeting has been despatched to shareholders, and also following the Meeting to confirm the outcome of the resolution to approve the appointment.

 

The Company makes this announcement in accordance with LR 9.6.11R of the Listing Rules. There are no other matters to be disclosed under LR9.6.13R in relation to the appointment of Hounaïda Lasry.

 

Enquiries

B&M European Value Retail S.A.

For further information please contact +44 (0) 151 728 5400

Alex Russo, Chief Executive Officer

Mike Schmidt, Chief Financial Officer

Investor.relations@bandmretail.com

 

Media

For media please contact +44 (0) 207 379 5151

Maitland

Sam Cartwright

bmstores-maitland@maitland.co.uk

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAEAPKEASXDEEA
Date   Source Headline
18th Jan 202211:11 amRNSHolding(s) in Company
18th Jan 202211:01 amRNSDirector/PDMR Shareholding
14th Jan 20227:00 amRNSResult of Secondary Placing of Ordinary Shares
13th Jan 20224:45 pmRNSProposed Secondary Placing of Ordinary Shares
13th Jan 20221:05 pmRNSBlock listing Interim Review
6th Jan 20227:00 amRNSQ3 FY22 Trading Update
30th Dec 20214:58 pmRNSPost Stabilisation Notice
9th Dec 20217:00 amRNSSpecial Dividend
24th Nov 202111:02 amRNSDirector/PDMR Notice
17th Nov 20213:48 pmRNSPricing of Senior Secured Notes Offering
15th Nov 20218:16 amRNSLaunch of Senior Secured Notes Offering
11th Nov 20217:00 amRNSFY22 Interim Results
10th Nov 20214:19 pmRNSHolding(s) in Company
10th Nov 202111:42 amRNSResult of Ordinary General Meeting
30th Sep 20219:00 amRNSTotal Voting Rights
30th Sep 20219:00 amRNSOrdinary General Meeting
16th Sep 20219:26 amRNSDirector/PDMR Shareholding
8th Sep 20219:36 amRNSTrading Update
12th Aug 20217:00 amRNSBoard Appointment
4th Aug 20218:00 amRNSBlock Listing Application
3rd Aug 202111:12 amRNSDirector/PDMR Shareholding
2nd Aug 202110:32 amRNSTotal Voting Rights
29th Jul 202112:16 pmRNSResult of AGM
20th Jul 202112:35 pmRNSDirector Declaration
16th Jul 20218:00 amRNSDirector/PDMR Shareholding
14th Jul 202111:22 amRNSDirector/PDMR Shareholding
13th Jul 20219:00 amRNSBlock listing Interim Review
8th Jul 20217:00 amRNSTrading Statement
21st Jun 20217:00 amRNSAnnual Financial Report
3rd Jun 20217:00 amRNSBoard Change
3rd Jun 20217:00 amRNSPreliminary Results
15th Mar 202110:16 amRNSHolding(s) in Company
4th Mar 20217:00 amRNSTrading Update
1st Mar 20219:48 amRNSTotal Voting Rights
25th Feb 20219:20 amRNSDirector Declaration
22nd Feb 20215:06 pmRNSDirector/PDMR Securities
10th Feb 20212:16 pmRNSHolding(s) in Company
9th Feb 202110:05 amRNSHolding(s) in Company
27th Jan 20217:00 amRNSHolding(s) in Company
20th Jan 20213:17 pmRNSHolding(s) in Company
20th Jan 202111:02 amRNSHolding(s) in Company
15th Jan 20214:02 pmRNSHolding(s) in Company
14th Jan 202112:52 pmRNSDirector/PDMR Shareholding
13th Jan 20219:24 amRNSBlock listing Interim Review
12th Jan 202110:00 amRNSDirector Declaration
12th Jan 20217:00 amRNSResults of Placing
11th Jan 20215:22 pmRNSProposed Secondary Placing
7th Jan 20217:00 amRNSTrading Statement
29th Dec 20209:25 amRNSDirector/PDMR Securities
29th Dec 20209:18 amRNSDirector/PDMR Securities

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.